▁London 10.375
, 4.6640625
▁UK 6.24609375
▁- 5.3984375
▁Ant 8.0859375
icip 3.0625
ation 1.46484375
▁is 3.705078125
▁building 6.53515625
▁within 5.88671875
▁the 0.78857421875
▁medical 6.64453125
▁community 2.302734375
▁as 4.0703125
▁anal 9.7578125
yst 0.439208984375
s 0.54248046875
▁eager 9.0234375
ly 0.309814453125
▁await 1.185546875
▁new 4.27734375
▁evidence 7.3359375
▁regarding 4.9921875
▁the 1.669921875
▁ground 7.60546875
- 4.71875
bre 0.923828125
aking 0.0199127197265625
▁anti 6.22265625
- 0.30078125
can 1.4638671875
cer 0.012664794921875
▁treatment 2.81640625
, 2.841796875
▁Mar 10.140625
im 8.4296875
ast 7.609375
at 4.38671875
, 2.3359375
▁developed 6.3671875
▁by 0.75146484375
▁British 6.953125
▁Bi 7.18359375
ote 4.234375
ch 0.89599609375
. 2.572265625
▁All 5.5625
▁eyes 6.44140625
▁are 0.55029296875
▁on 0.67822265625
▁the 1.015625
▁up 4.59375
coming 0.2900390625
▁European 7.19140625
▁Society 6.3046875
▁for 1.1494140625
▁Medical 0.2071533203125
▁On 0.6435546875
col 0.006622314453125
ogy 0.0006613731384277344
▁( 1.087890625
ES 0.13525390625
MO 0.005710601806640625
) 0.1710205078125
▁meeting 2.841796875
▁where 3.91796875
▁the 1.5849609375
▁latest 2.98046875
▁research 2.9375
▁on 2.20703125
▁this 3.025390625
▁potential 6.0546875
▁game 3.125
- 0.2333984375
ch 0.0246429443359375
anger 1.2919921875
▁will 1.3310546875
▁be 0.33349609375
▁presented 1.1318359375
. 0.62939453125
<0x0A> 0.99169921875
Mar 3.4609375
im 0.5693359375
ast 0.032196044921875
at 0.0110626220703125
▁has 3.53125
▁been 1.0380859375
▁creating 7.82421875
▁a 1.3837890625
▁bu 0.71484375
zz 0.00024962425231933594
▁within 2.830078125
▁the 0.10565185546875
▁scientific 3.939453125
▁community 0.271484375
▁due 3.95703125
▁to 0.0186614990234375
▁its 0.630859375
▁potential 2.0078125
▁to 0.81640625
▁revolution 2.2890625
ize 0.1644287109375
▁cancer 1.37109375
▁care 2.392578125
. 0.9716796875
▁The 1.7998046875
▁treatment 3.68359375
, 2.33203125
▁designed 4.39453125
▁to 0.356201171875
▁in 4.36328125
hib 0.0377197265625
it 0.0024204254150390625
▁cancer 2.310546875
▁cell 1.3359375
▁growth 0.7265625
▁and 1.7802734375
▁met 2.455078125
ast 0.14306640625
asis 0.06201171875
, 0.423095703125
▁has 1.5458984375
▁shown 2.27734375
▁remarkable 2.62890625
▁promise 1.439453125
▁in 0.53515625
▁early 3.388671875
▁tri 2.46484375
als 0.0006475448608398438
. 1.2587890625
▁However 4.37890625
, 0.0343017578125
▁detailed 8.734375
▁evidence 4.5390625
▁of 1.580078125
▁its 1.40234375
▁effect 1.91796875
iveness 0.0419921875
▁remains 3.0078125
▁sc 4.34375
ant 0.0025653839111328125
, 1.6572265625
▁spark 8.2109375
ing 0.0007987022399902344
▁great 4.359375
▁interest 0.61865234375
▁in 1.2060546875
▁the 1.0166015625
▁forth 7.35546875
coming 0.00231170654296875
▁ES 0.63427734375
MO 0.0013647079467773438
▁meeting 0.5673828125
. 0.65087890625
<0x0A> 0.4501953125
D 5.08203125
uring 1.02734375
▁the 0.583984375
▁virtual 7.2421875
▁event 4.28515625
, 0.359375
▁scheduled 3.552734375
▁for 0.44482421875
▁next 5.33203125
▁month 1.0380859375
, 0.1544189453125
▁British 5.56640625
▁Bi 0.444091796875
ote 0.00417327880859375
ch 0.025726318359375
▁will 0.8564453125
▁present 2.607421875
▁new 2.41015625
▁clin 3.64453125
ical 0.00457000732421875
▁data 1.03515625
▁and 2.19140625
▁research 2.984375
▁find 2.119140625
ings 1.537799835205078e-05
▁that 2.525390625
▁del 7.02734375
ve 0.2264404296875
▁deeper 0.98681640625
▁into 0.039154052734375
▁the 0.347900390625
▁potential 1.841796875
▁of 0.61376953125
▁Mar 0.437255859375
im 0.0016317367553710938
ast 0.003574371337890625
at 0.001972198486328125
. 1.33984375
▁The 1.5966796875
▁company 1.7353515625
' 1.623046875
s 0.0005946159362792969
▁represent 5.7734375
atives 0.00012552738189697266
▁aim 5.83984375
▁to 0.0177154541015625
▁shed 2.662109375
▁light 0.497802734375
▁on 0.03155517578125
▁the 0.61474609375
▁treatment 3.1640625
’ 28.90625
s 2.515625
▁effect 3.525390625
iveness 0.154541015625
, 1.380859375
▁safety 2.677734375
▁profile 2.578125
, 0.313232421875
▁and 0.43359375
▁its 3.634765625
▁potential 1.4755859375
▁use 3.9296875
▁in 0.454345703125
▁various 3.046875
▁cancer 1.5029296875
▁types 0.58740234375
. 0.43359375
<0x0A> 0.57666015625
Anal 6.42578125
yst 0.03533935546875
s 0.0711669921875
, 3.439453125
▁invest 2.650390625
ors 0.0144500732421875
, 0.1597900390625
▁and 0.1353759765625
▁medical 2.99609375
▁profession 0.52294921875
als 0.0006699562072753906
▁have 3.482421875
▁been 1.0537109375
▁closely 3.216796875
▁following 0.63232421875
▁the 0.9130859375
▁development 2.08984375
▁of 0.148681640625
▁Mar 0.34716796875
im 0.002445220947265625
ast 0.004116058349609375
at 0.0027942657470703125
▁for 3.181640625
▁its 3.86328125
▁potential 0.65283203125
▁impact 3.1640625
▁on 0.320068359375
▁cancer 0.82373046875
▁treatment 1.390625
. 0.323486328125
▁The 1.59375
▁anticip 6.48828125
ation 1.1435546875
▁lies 7.80078125
▁not 4.8359375
▁only 0.2388916015625
▁in 0.30029296875
▁the 0.376953125
▁hope 4.8515625
▁for 2.29296875
▁a 1.017578125
▁break 2.322265625
through 0.01210784912109375
▁ther 4.34765625
apy 0.00292205810546875
▁but 1.7724609375
▁also 0.2392578125
▁the 2.396484375
▁potential 1.91015625
▁financial 4.5390625
▁imp 3.033203125
lications 0.0435791015625
▁for 1.97265625
▁British 1.0625
▁Bi 0.01186370849609375
ote 0.0009431838989257812
ch 0.00441741943359375
. 0.818359375
<0x0A> 0.64306640625
Wh 4.5703125
ile 0.060882568359375
▁the 1.1767578125
▁effic 5.36328125
acy 0.00040793418884277344
▁of 0.437744140625
▁Mar 0.411865234375
im 0.0014801025390625
ast 0.00325775146484375
at 0.0036830902099609375
▁will 4.75390625
▁be 0.67333984375
▁a 3.40234375
▁key 1.36328125
▁focus 1.392578125
▁of 1.146484375
▁the 0.6142578125
▁ES 1.0908203125
MO 0.0005507469177246094
▁event 2.28125
, 0.046630859375
▁exper 5.78515625
ts 0.0003142356872558594
▁also 2.41796875
▁keen 7.55859375
ly 0.2352294921875
▁await 0.77587890625
▁any 3.216796875
▁updates 2.251953125
▁on 0.56591796875
▁possible 5.43359375
▁side 2.51953125
▁effects 0.1102294921875
▁and 1.15625
▁challeng 6.296875
es 0.01387786865234375
▁associated 2.13671875
▁with 0.006450653076171875
▁its 1.1943359375
▁use 0.487060546875
. 0.1494140625
▁This 3.708984375
▁information 3.71875
▁will 0.66552734375
▁be 1.3076171875
▁vital 2.568359375
▁for 1.251953125
▁g 7.890625
aug 0.007144927978515625
ing 3.719329833984375e-05
▁its 2.123046875
▁potential 1.6533203125
▁as 2.732421875
▁an 2.212890625
▁effective 1.009765625
▁treatment 1.2265625
▁option 1.5986328125
, 2.421875
▁ens 6.328125
uring 0.0007505416870117188
▁patient 3.10546875
▁safety 0.21044921875
, 2.607421875
▁and 0.207763671875
▁inform 4.34375
ing 0.0034942626953125
▁future 2.009765625
▁research 1.591796875
▁efforts 2.796875
. 0.1258544921875
<0x0A> 0.14013671875
The 2.39453125
▁up 2.99609375
coming 0.0017290115356445312
▁ES 0.388916015625
MO 0.0006580352783203125
▁meeting 0.4013671875
▁promises 3.025390625
▁to 0.05670166015625
▁provide 2.130859375
▁a 1.8798828125
▁significant 4.0625
▁le 8.65625
ap 0.0286712646484375
▁forward 0.2359619140625
▁in 0.4873046875
▁our 3.3828125
▁understanding 0.06915283203125
▁of 0.0251922607421875
▁British 10.140625
▁Bi 0.0037021636962890625
ote 0.0013141632080078125
ch 0.023681640625
' 0.09918212890625
s 0.003040313720703125
▁anti 4.88671875
- 0.0029697418212890625
can 0.0231781005859375
cer 0.0011081695556640625
▁treatment 0.5986328125
, 1.2216796875
▁Mar 0.2451171875
im 0.0007405281066894531
ast 0.00217437744140625
at 0.0004291534423828125
. 0.161376953125
▁Anal 2.6328125
yst 0.0011501312255859375
s 0.002849578857421875
▁eager 2.638671875
ly 0.03704833984375
▁await 0.3203125
▁this 3.26953125
▁opportunity 2.81640625
▁to 0.07391357421875
▁dig 5.68359375
est 4.546875
▁the 0.7099609375
▁new 3.1875
▁data 1.4384765625
▁and 0.346435546875
▁explore 4.23828125
▁the 0.7265625
▁potential 0.83544921875
▁applications 4.3203125
▁of 0.489501953125
▁this 1.1484375
▁cutting 4.0546875
- 0.0091094970703125
edge 0.0013666152954101562
▁ther 1.3076171875
apy 0.0017709732055664062
. 0.253173828125
